Evidence map›Paper›PMID 23826242›Full record

ArticlePloS one2013

Changes in B Cell Populations and Merozoite Surface Protein-1-Specific Memory B Cell Responses after Prolonged Absence of Detectable P. falciparum Infection.

Cyrus Ayieko, Alexander C Maue, Walter G Z O Jura, Gregory S Noland, George Ayodo, Rosemary Rochford, Chandy C John

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Development of high affinity antibodies toFrontiers in immunology · 2025
    Article
  4. Article
  5. Article
  6. Differences in phenotype between long-lived memory B cells againstbioRxiv : the preprint server for biology · 2024
    Article
  7. Review
  8. Article
  9. Frontiers in immunology · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Follicular helper T cell and memory B cell immunity in CHC patients.Journal of molecular medicine (Berlin, Germany) · 2019
    Article
  17. TFrontiers in immunology · 2019
    Review
  18. Development of B Cell Memory in Malaria.Frontiers in immunology · 2019
    Review
  19. eLife · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Cyrus AyiekoMaseno University, Maseno, Kenya.
Alexander C Maue
Walter G Z O Jura
Gregory S Noland
George Ayodo
Rosemary Rochford
Chandy C John
Maseno University · KESUNY Upstate Medical University · USUniversity of Minnesota Medical Center · USKenya Medical Research Institute · KE

Funding

Viral and Host Determinants of HIV-1 TransmissionU01AI067854 · NIAID · DUKE UNIVERSITY · PI HARRISON, STEPHEN COPLAN · 2005 to 2005
$14.9M
Effects of Malaria on EBV Persistence in ChildrenR01CA102667 · NCI · UPSTATE MEDICAL UNIVERSITY · PI ROCHFORD, ROSEMARY · 2005 to 2014
$2.9M
Translational Research in Malaria Transmission and Immunity in KenyaD43TW008085 · FIC · UNIVERSITY OF MINNESOTA · PI JOHN, CHANDY C. · 2008 to 2012
$752k
FIC NIH HHS D43 TW008085NCI NIH HHS R01 CA102667NIAID NIH HHS U01 AI067854
6 · The paper itself

Abstract

Clinical immunity to malaria declines in the absence of repeated parasite exposure. However, little is known about how B cell populations and antigen-specific memory B cells change in the absence of P. falciparum infection. A successful indoor residual insecticide spraying campaign in a highland area of western Kenya, led to an absence of blood-stage P. falciparum infection between March 2007 and April 2008. We assessed memory B cell responses in 45 adults at the beginning (April 2008) and end (April 2009) of a subsequent 12-month period during which none of the adults had evidence of asymptomatic parasitemia or clinical disease. Antibodies and memory B cells to the 42-kDa portion of the merozoite surface protein-1 (MSP-142) were measured using ELISA and ELISPOT assays, respectively. B cell populations were characterized by flow cytometry. From 2008 to 2009, the prevalence of MSP-142-specific memory B cells (45% vs. 55%, respectively, P = 0.32) or antibodies (91% vs. 82%, respectively, P = 0.32) did not differ significantly, although specific individuals did change from positive to negative and vice versa, particularly for memory B cells, suggesting possible low-level undetected parasitemia may have occurred in some individuals. The magnitude of MSP-142-specific memory B cells and levels of antibodies to MSP-142 also did not differ from 2008 to 2009 (P>0.10 for both). However, from 2008 to 2009 the proportions of both class-switched atypical (CD19+IgD-CD27-CD21-IgM-) and class-switched activated (CD19+IgD-CD27+CD21-IgM-) memory B cells decreased (both P<0.001). In contrast, class-switched resting classical memory B cells (CD19+IgD-CD27+CD21+IgM-) increased (P<0.001). In this area of seasonal malaria transmission, a one- year absence of detectable P. falciparum infection was not associated with changes in the prevalence or level of MSP-142 specific memory B cells, but was associated with major changes in overall memory B cell subsets.

Indexed as

Plasmodium falciparumAdolescentAdultAgedAntibodiesAntibodies, BacterialB-LymphocytesFemaleHumansImmunologic MemoryKenyaMalaria, FalciparumMaleMerozoite Surface Protein 1Middle AgedPhenotypeAntibodiesAntibodies, BacterialMerozoite Surface Protein 1Tetanus Toxoid

Identifiers

PMID23826242
PMCPMC3695086
OpenAlexW2119718196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.